loadpatents
Patent applications and USPTO patent grants for La Thangue; Nicholas B..The latest application filed is for "screening method".
Patent | Date |
---|---|
Screening method Grant 10,012,652 - La Thangue , et al. July 3, 2 | 2018-07-03 |
Screening Method App 20170219594 - La Thangue; Nicholas B. ;   et al. | 2017-08-03 |
Screening method Grant 9,347,103 - La Thangue , et al. May 24, 2 | 2016-05-24 |
Biomarkers For Prognosis App 20160069887 - La Thangue; Nicholas B. | 2016-03-10 |
Screening Method App 20140369999 - La Thangue; Nicholas B. ;   et al. | 2014-12-18 |
Screening method Grant 8,784,806 - La Thangue , et al. July 22, 2 | 2014-07-22 |
Screening Method App 20090311244 - La Thangue; Nicholas B. ;   et al. | 2009-12-17 |
Peptide antagonists of DP transcription factors Grant 7,160,981 - La Thangue , et al. January 9, 2 | 2007-01-09 |
Transcription factor - E2F-5 App 20030022260 - La Thangue, Nicholas B. ;   et al. | 2003-01-30 |
Peptide antagonists of DP transcription factors App 20020103121 - La Thangue, Nicholas B. ;   et al. | 2002-08-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.